NxStage Medical Inc.
439 South Union St
5th Fl
Lawrence
MA
01843
United States
(978) 687-4700
Product(s):
Manufactures systems for the treatment of end-stage renal disease and acute kidney failure
Employees:
170 (1221)
Ownership:
Public
Exchange:
NSDQ
symbol:
NXTM
2004 Revenue:
$1,885,000
2005 Revenue:
$5,994,000
2006 Revenue:
$20,812,000
2007 Revenue:
$59,964,000
2008 Revenue:
$128,763,000
Yahoo Quotes:
CEO:
Jeffrey H. Burbank, CEO/President Management:
Agustin M. Azel, SVP-Manufacturing
Robert S. Brown, SVP, CFO
Thomas F. Shea, SVP-Operations
Winifred L. Swan, SVP, Secretary, General Counsel
Joseph E. Turk Jr., SVP-Commercial Operations
Michael J. Webb, SVP-Quality, Regulatory & Clinical Affairs
NxStage Medical Inc.
Printer-friendly versionPermalink
Top News Stories
RECENT BLOG POSTS
- Chance-takers are accident-makers
- Weekly Wireless Roundup: Express Scripts inks pilot deal for GlowCap
- MedGadget's MedTech Monday: Croc mummy tomography
- Congress is incapable of a positive contribution to health care reimbursement
- Technically speaking, you don't always have to be technical
- Weekly Wireless Roundup: Updates from HIMSS
- MedGadget's MedTech Monday: A simulator teaches surgeons how to use da Vinci Robot
- Out of sight, out of mind?
- Weekly Wireless Roundup: Is consumer ultrasound dangerous & irresponsible?
- MedGadget's MedTech Monday: Artificial foot saves energy every step of the way
Navigation
